| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Candel Therapeutics, Inc. (CADL) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. CADL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.21M | $19.34M | - | |
| CEO | 629.0K | $5.50M | - | |
| CFO | 232.0K | $2.03M | - | |
| Other | 232.0K | $2.03M | - | |
| Other | 154.0K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Caffo Nathan | Chief Business Officer | Buy | 6,000 | $8.00 | $48,000.00 | New | +57.5% | -57.5% | |
| Jul 29, 2021 | Tak Paul Peter58 | Chief Executive Officer | Buy | 25,000 | $8.00 | $200,000.00 | New | +57.5% | -57.5% | |
| Jul 29, 2021 | Canepa John J | Chief Financial Officer | Buy | 10,125 | $8.00 | $81,000.00 | New | +57.5% | -57.5% | |
| Jul 29, 2021 | Nguyen Diem | Director | Buy | 10,000 | $8.00 | $80,000.00 | New | +57.5% | -57.5% | |
| Jul 29, 2021 | Martell Christopher | Director | Buy | 125,000 | $8.00 | $1,000,000.00 | New | +57.5% | -57.5% | |
| Jul 29, 2021 | Manning Paul B53 | Director | Buy | 56,000 | $7.34 | $410,778.00 | +155.6% | +57.5% | -57.5% |